Pascal Bourquard

1.4k total citations
19 papers, 530 citations indexed

About

Pascal Bourquard is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Pascal Bourquard has authored 19 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 6 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Pascal Bourquard's work include Multiple Myeloma Research and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Pascal Bourquard is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Pascal Bourquard collaborates with scholars based in France, United Kingdom and Switzerland. Pascal Bourquard's co-authors include Pierre Quartier, A.-M. Stoppa, Bruno Hurault de Ligny, Yves Réguerre, Anne‐Sophie Carret, J. L. Garnier, B. Vasseur, C. Antoine, A. Mathieu-Boué and Albert Faye and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Cell Cycle.

In The Last Decade

Pascal Bourquard

18 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Bourquard France 10 271 197 119 105 96 19 530
Yoshihito Hayami Japan 13 154 0.6× 197 1.0× 155 1.3× 99 0.9× 169 1.8× 26 583
Keisuke Kawamoto Japan 14 245 0.9× 279 1.4× 99 0.8× 142 1.4× 60 0.6× 48 646
Nongnit Lewin Sweden 13 246 0.9× 163 0.8× 49 0.4× 219 2.1× 145 1.5× 32 569
Lekidelu Taddesse-Heath United States 12 491 1.8× 486 2.5× 64 0.5× 160 1.5× 137 1.4× 21 795
Therese White United States 11 195 0.7× 229 1.2× 98 0.8× 169 1.6× 125 1.3× 22 557
Cedith M. Copenhaver United States 11 200 0.7× 212 1.1× 36 0.3× 93 0.9× 71 0.7× 12 424
Katie Seo United States 11 116 0.4× 142 0.7× 189 1.6× 124 1.2× 114 1.2× 14 528
Lori A. Leslie United States 11 252 0.9× 168 0.9× 48 0.4× 125 1.2× 61 0.6× 73 412
R Angonin France 13 140 0.5× 195 1.0× 111 0.9× 138 1.3× 121 1.3× 31 693
Keitaro Tsushita Japan 12 412 1.5× 429 2.2× 135 1.1× 240 2.3× 219 2.3× 25 818

Countries citing papers authored by Pascal Bourquard

Since Specialization
Citations

This map shows the geographic impact of Pascal Bourquard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Bourquard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Bourquard more than expected).

Fields of papers citing papers by Pascal Bourquard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Bourquard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Bourquard. The network helps show where Pascal Bourquard may publish in the future.

Co-authorship network of co-authors of Pascal Bourquard

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Bourquard. A scholar is included among the top collaborators of Pascal Bourquard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Bourquard. Pascal Bourquard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Fouquet, Guillemette, Alain Duhamel, Salomon Manier, et al.. (2019). Maintenance with weekly carfilzomib in elderly newly diagnosed multiple myeloma (IFM 2012-03).. Journal of Clinical Oncology. 37(15_suppl). 8029–8029. 2 indexed citations
2.
3.
4.
Leleu, Xavier, Guillemette Fouquet, Lionel Karlin, et al.. (2017). Carfilzomib weekly-melphalan-prednisone in untreated elderly multiple myeloma: IFM2012-03.. Journal of Clinical Oncology. 35(15_suppl). 8004–8004. 1 indexed citations
5.
Chiésa, Jean, Véronique Dorvaux, Vincent Gâtinois, et al.. (2017). An incidental finding of maternal multiple myeloma by non invasive prenatal testing. Prenatal Diagnosis. 37(12). 1257–1260. 9 indexed citations
6.
Bourquard, Pascal, et al.. (2014). Plasmocytomes cutanés primitifs multiples. Annales de Dermatologie et de Vénéréologie. 141(5). 364–368. 2 indexed citations
7.
Kassambara, Alboukadel, Surinder S. Sahota, Thierry Rème, et al.. (2013). DNA repair pathways in human multiple myeloma. Cell Cycle. 12(17). 2760–2773. 53 indexed citations
8.
Ianotto, Jean‐Christophe, Elisabeth Hardy, Valérie Ugo, et al.. (2007). Inhibitory effect of the substance P and its derivative on erythropoietin-independent growth of erythroid progenitors in polycythemia vera. Leukemia Research. 32(5). 743–754. 1 indexed citations
9.
Douet‐Guilbert, Nathalie, Fréderic Morel, Marie‐Josée Le Bris, et al.. (2005). Jumping translocations in multiple myeloma. Cancer Genetics and Cytogenetics. 161(2). 159–163. 13 indexed citations
10.
Douet‐Guilbert, Nathalie, Fréderic Morel, Marie‐Josée Le Bris, et al.. (2005). Rearrangement of the MLL gene in acute myeloblastic leukemia: report of two rare translocations. Cancer Genetics and Cytogenetics. 157(2). 169–174. 7 indexed citations
11.
Bertrand, Arnaud, Nathalie Douet‐Guilbert, Fréderic Morel, et al.. (2005). Screening by fluorescence in situ hybridization for MLL status at diagnosis in 239 unselected patients with acute myeloblastic leukemia. Cancer Genetics and Cytogenetics. 161(2). 110–115. 6 indexed citations
12.
Douet‐Guilbert, Nathalie, Fréderic Morel, Marie‐Josée Le Bris, et al.. (2004). Interphase FISH for follow-up of Philadelphia chromosome-positive chronic myeloid leukemia treatment.. PubMed. 24(4). 2535–9. 9 indexed citations
13.
Morel, Fréderic, Marie‐Josée Le Bris, Angèle Herry, et al.. (2003). Deletion of the 5'ABL Region in Philadelphia Chromosome Positive Chronic Myeloid Leukemia: Frequency, Origin and Prognosis. Leukemia & lymphoma. 44(8). 1333–1338. 12 indexed citations
14.
Lavabre‐Bertrand, Thierry, Pascal Bourquard, Jean Chiésa, et al.. (2001). Diabetes insipidus revealing acute myelogenous leukaemia with a high platelet count, monosomy 7 and abnormalities of chromosome 3: a new entity?. European Journal Of Haematology. 66(1). 66–69. 25 indexed citations
15.
Milpied, Nöel, B. Vasseur, Nathalie Parquet, et al.. (2000). Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients. Annals of Oncology. 11. S113–S116. 285 indexed citations
16.
Lavabre‐Bertrand, Thierry, et al.. (1994). CD23 Antigen Density is Related to Serum Gamma Globulin Level, Bone Marrow Reticulin Pattern, and Treatment in B Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 13(1-2). 89–94. 12 indexed citations
17.
Lavabre‐Bertrand, Thierry, Christophe Duperray, Corinne Brunet, et al.. (1994). Quantification of CD24 and CD45 antigens in parallel allows a precise determination of B-cell maturation stages: relevance for the study of B-cell neoplasias.. PubMed. 8(3). 402–8. 52 indexed citations
18.
Lavabre‐Bertrand, Thierry, et al.. (1994). Leukemia-associated changes identified by quantitative flow cytometry. II. CD5 over-expression and monitoring in B-CLL.. PubMed. 8(9). 1557–63. 24 indexed citations
19.
Etienne‐Julan, Maryse, Pierre Roux, Pascal Bourquard, et al.. (1992). Cell targeting by murine recombinant retroviruses.. PubMed. 9 Suppl 1. 139–42. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshihito Hayami Breakdown of academic impact, for papers by Keisuke Kawamoto Breakdown of academic impact, for papers by Nongnit Lewin Breakdown of academic impact, for papers by Lekidelu Taddesse-Heath Breakdown of academic impact, for papers by Therese White Breakdown of academic impact, for papers by Cedith M. Copenhaver Breakdown of academic impact, for papers by Katie Seo Breakdown of academic impact, for papers by Lori A. Leslie Breakdown of academic impact, for papers by R Angonin Breakdown of academic impact, for papers by Keitaro Tsushita
Rankless by CCL
2026